Literature DB >> 31563212

Portal Hypertension: Pathogenesis and Diagnosis.

Laura Turco1, Guadalupe Garcia-Tsao2.   

Abstract

Portal hypertension (PH) is an increase in the pressure gradient between portal vein and inferior vena cava. Increased resistance occurs at different levels within the portal venous system, followed by increased portal venous inflow. PH is the main driver of cirrhosis decompensation. Varices on endoscopy or portosystemic collaterals on imaging indicate PH. Although its cause is determined mostly via noninvasive tests, the gold standard to measure portal pressure in cirrhosis and determine its severity is hepatic vein catheterization with determination of the hepatic venous pressure gradient. Measuring portal pressure is essential in proof-of-concept studies of portal pressure-lowering drugs.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ascites; Bleeding; Cirrhosis; Gastroesophageal varices; Hepatic venous pressure gradient; Liver stiffness

Year:  2019        PMID: 31563212     DOI: 10.1016/j.cld.2019.07.007

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  9 in total

1.  Overview of Current Management of Portal Hypertension.

Authors:  Guadalupe Garcia-Tsao
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-01

Review 2.  Portal pressure reductions induced by nonselective beta-blockers improve outcomes and decrease mortality in patients with cirrhosis with and without ascites.

Authors:  Laura Turco; Guadalupe García-Tsao
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-06-03

3.  Identification of RPL5 gene variants and the risk of hepatic vein thrombosis in Saudi patients.

Authors:  Fathelrahman M Hassan; Afnan A Alsultan; Faisal Alzahrani; Waleed H Albuali; Dalal K Bubshait; Elfadil M Abass; Mudathir A Elbasheer; Abdulmohsen A Alkhanbashi
Journal:  Saudi Med J       Date:  2021-09       Impact factor: 1.422

4.  Update on the Evaluation and Management of Portal Hypertension.

Authors:  Gabriella Aitcheson; Carensa Cezar; Irene John; Binu V John
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-12

5.  Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.

Authors:  Zhong Wang; Yi-Fan Wu; Zhen-Dong Yue; Hong-Wei Zhao; Lei Wang; Zhen-Hua Fan; Yu Zhang; Fu-Quan Liu
Journal:  World J Gastroenterol       Date:  2021-02-07       Impact factor: 5.742

6.  Laparoscopic splenectomy and devascularization for massive splenomegaly in portal hypertensive patients: a retrospective study of a single surgical team's experience with 6-year follow-up data.

Authors:  Dong Wang; Xiao Chen; Ling Lv; Tao Yang; Bo Huang; Yanlong Cao; Jianguo Lu; Jikai Yin
Journal:  Ann Transl Med       Date:  2022-02

7.  Detection of liver and spleen stiffness in rats with portal hypertension by two-dimensional shear wave elastography.

Authors:  YongJian Chen; JingYun Li; Qin Zhou; GuoRong Lyu; ShiLin Li
Journal:  BMC Med Imaging       Date:  2022-04-13       Impact factor: 1.930

Review 8.  Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension.

Authors:  Wolfgang Kreisel; Denise Schaffner; Adhara Lazaro; Jonel Trebicka; Irmgard Merfort; Annette Schmitt-Graeff; Peter Deibert
Journal:  Int J Mol Sci       Date:  2020-08-28       Impact factor: 5.923

9.  Hemodynamic Evaluation of the Right Heart-Pulmonary Circulation Unit in Patients Candidate to Transjugular Intrahepatic Portosystemic Shunt.

Authors:  Giulia Manguso; Anthony Vignone; Manuela Merli; Cristiano Miotti; Annalisa Caputo; Carmine Dario Vizza; Roberto Badagliacca
Journal:  J Clin Med       Date:  2022-01-17       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.